Earnings Feed
Start Free
Home/Filings/4/0001415889-22-003740
4//SEC Filing

Weber David M 4

Accession 0001415889-22-003740

CIK 0000815094other
View on SEC.govCompany Profile

Filed

Apr 3, 8:00 PM ET

Accepted

Apr 4, 5:07 PM ET

Size

20.4 KB

Accession

0001415889-22-003740

Insider Transaction Report

Form 4
Period: 2022-03-31
ABIOMED INCNASD
Weber David M
Chief Operating Officer
Transactions
  • Sale

    Common Stock, $.01 par value

    2022-03-31$340.00/sh−7,500$2,550,000→ 116,314 total
Holdings

  • Stock Option (right to buy)

    Exercise: $134.51From: 2018-05-15Exp: 2027-05-15→ Common Stock (0 underlying)
    8,000

  • Stock Option (right to buy)

    Exercise: $381.97From: 2019-05-16Exp: 2028-05-16→ Common Stock (0 underlying)
    6,500

  • Common Stock, $.01 par value

    (indirect: By Trust)
    15,497

  • Stock Option (right to buy)

    Exercise: $223.90From: 2021-05-29Exp: 2030-05-29→ Common Stock (0 underlying)
    5,000

  • Stock Option (right to buy)

    Exercise: $99.62From: 2017-05-24Exp: 2026-05-24→ Common Stock (0 underlying)
    7,000

  • Stock Option (right to buy)

    Exercise: $66.25From: 2016-05-13Exp: 2025-05-13→ Common Stock (0 underlying)
    10,000

  • Stock Option (right to buy)

    Exercise: $266.39From: 2020-05-30Exp: 2029-05-30→ Common Stock (0 underlying)
    6,000

  • Stock Option (right to buy)

    Exercise: $283.88From: 2022-05-25Exp: 2031-05-25→ Common Stock (0 underlying)
    4,969
Footnotes (5)
  • [F1]Sale of common stock pursuant to reporting owner's 10b5-1 plan.
  • [F2]This price represents the sale price of the transactions on the reported date at $340.00. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
  • [F3]Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan.
  • [F4]These options become exercisable in annual 33-1/3% increments, commencing on the date shown in Table II, Column 6.
  • [F5]Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2015 Omnibus Incentive Plan.

Documents

2 files

Issuer

ABIOMED INC

CIK 0000815094

→
Entity typeother

Related Parties

1
  • filerCIK 0001399519

Filing Metadata

Form type
4
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 5:07 PM ET
Size
20.4 KB
View on SEC.gov